Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
InhaleRx Limited ( (AU:IRX) ) has shared an update.
InhaleRx Limited has announced a proposed issue of 6,000,000 unlisted options with an exercise price of $0.042, set to expire on December 22, 2027. This strategic move is intended to strengthen the company’s financial position and support its ongoing operations, potentially enhancing its market presence and offering growth opportunities for stakeholders.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based therapeutic products. The company primarily targets the medical cannabis and respiratory health markets, aiming to provide innovative solutions for patients requiring inhaled medications.
Average Trading Volume: 257,297
Technical Sentiment Signal: Hold
Current Market Cap: A$7.85M
See more data about IRX stock on TipRanks’ Stock Analysis page.